Literature DB >> 22203422

TOP2 gene is involved in the pathogenicity of Candida albicans.

Hao Zheng1, Yong-Sheng Yu.   

Abstract

Candida albicans is a common cause of morbidity in hospitalized and immunosuppressed patients. There are still many unknown genes involved in the virulence of C. albicans. The present study aims to examine the effect of TOP2 gene in candidal virulence, including hyphal growth, phospholipase and proteinase activity. Targeted gene disruption of both TOP2 alleles in a wild-type strain of C. albicans produced hyphae more efficiently. TOP2 disruption also increased phospholipase and proteinase activities, and enhanced virulence as assessed by host tissue colonization in systemic infection model. The result of reverse transcription PCR displayed that PLB1 and SAP4 expressions of top2 mutants was significantly upregulated when compared with the isogenic parental strain. Together, these results indicated that TOP2 gene was involved in candidal pathogenicity, and the major reasons for the comparatively high virulence of null mutants were the higher capacity to produce hyphae and the increased phospholipase and proteinase activities, at least in part.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22203422     DOI: 10.1007/s11010-011-1203-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  25 in total

Review 1.  Transcription factors in Candida albicans - environmental control of morphogenesis.

Authors:  J F Ernst
Journal:  Microbiology       Date:  2000-08       Impact factor: 2.777

Review 2.  Bacterial phospholipases and their role in virulence.

Authors:  J G Songer
Journal:  Trends Microbiol       Date:  1997-04       Impact factor: 17.079

3.  Nonfilamentous C. albicans mutants are avirulent.

Authors:  H J Lo; J R Köhler; B DiDomenico; D Loebenberg; A Cacciapuoti; G R Fink
Journal:  Cell       Date:  1997-09-05       Impact factor: 41.582

Review 4.  Invasive fungal infections: evolving challenges for diagnosis and therapeutics.

Authors:  Michael Ellis
Journal:  Mol Immunol       Date:  2002-05       Impact factor: 4.407

5.  An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans.

Authors:  K L Lee; H R Buckley; C C Campbell
Journal:  Sabouraudia       Date:  1975-07

6.  Real-time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and -independent gene expression.

Authors:  Heleen Nailis; Sona Kucharíková; Markéta Ricicová; Patrick Van Dijck; Dieter Deforce; Hans Nelis; Tom Coenye
Journal:  BMC Microbiol       Date:  2010-04-16       Impact factor: 3.605

7.  Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog.

Authors:  H Liu; J Köhler; G R Fink
Journal:  Science       Date:  1994-12-09       Impact factor: 47.728

8.  Multiplicity of genes encoding secreted aspartic proteinases in Candida species.

Authors:  M Monod; G Togni; B Hube; D Sanglard
Journal:  Mol Microbiol       Date:  1994-07       Impact factor: 3.501

9.  Plate method for detection of phospholipase activity in Candida albicans.

Authors:  M F Price; I D Wilkinson; L O Gentry
Journal:  Sabouraudia       Date:  1982-03

10.  Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus.

Authors:  Alexandra Brand; Donna M MacCallum; Alistair J P Brown; Neil A R Gow; Frank C Odds
Journal:  Eukaryot Cell       Date:  2004-08
View more
  1 in total

Review 1.  DNA damage checkpoint and repair: From the budding yeast Saccharomyces cerevisiae to the pathogenic fungus Candida albicans.

Authors:  Shuangyan Yao; Yuting Feng; Yan Zhang; Jinrong Feng
Journal:  Comput Struct Biotechnol J       Date:  2021-11-25       Impact factor: 7.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.